Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation

被引:108
作者
Naisbitt, DJ
Farrell, J
Gordon, SF
Maggs, JL
Burkhart, C
Pichler, WJ
Pirmohamed, M
Park, BK
机构
[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3BX, Merseyside, England
[2] Univ Bern, Inselspital, Div Rheumatol & Clin Immunol Allegol, CH-3010 Bern, Switzerland
关键词
D O I
10.1124/mol.62.3.628
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Treatment with sulfamethoxazole (SMX) can lead to hypersensitivity reactions. T cells from hypersensitive patients recognize either the parent drug and/or the reactive nitroso (SMX-NO) metabolite. In this study, using a novel in vitro rat splenocyte assay, we have investigated the toxicological and immunological consequences of cell surface haptenation by SMX-NO. SMX-NO was found to be unstable in solution; spontaneous transformation yielded appreciable amounts of SMX-hydroxylamine, nitro-SMX, and the previously unknown azoxy and azo dimers within 15 min. Irreversible binding of SMX-NO to cellular protein was demonstrated by flow cytometry, with haptenation being greater on the surface of antigen-presenting cells than on T cells. The consequences of irreversible binding of SMX-NO were examined in two ways. First, haptenation above a threshold level led to a proportionate increase in cell death (both apoptosis and necrosis). Indeed, the cells that became haptenated were the same as those that underwent necrotic cell death. Second, sensitized splenocytes proliferated in the presence of major histocompatibility complex (MHC)-restricted antigen derived from both viable and dead cells haptenated with low and high levels of SMX-NO, respectively. However, direct modification of MHC by SMX-NO was not the mechanism of antigen presentation. The antigenic threshold of SMX-NO for T-cell proliferation and toxicity was estimated to be between 0.5 and 1 muM and 5 to 10 muM, respectively. The potential of SMX-NO to generate a potent antigen and cause cytotoxicity may in combination provide the signals necessary to induce a hypersensitivity reaction to SMX.
引用
收藏
页码:628 / 637
页数:10
相关论文
共 40 条
[1]  
Barranco P., 1998, Clinical and Experimental Allergy, V28, P61
[2]   Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+T-cells [J].
Burkhart, C ;
Von Greyerz, S ;
Depta, JPH ;
Naisbitt, DJ ;
Britschgi, M ;
Park, KB ;
Pichler, WJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (03) :623-630
[3]  
CRIBB AE, 1991, DRUG METAB DISPOS, V19, P900
[4]   SULFAMETHOXAZOLE IS METABOLIZED TO THE HYDROXYLAMINE IN HUMANS [J].
CRIBB, AE ;
SPIELBERG, SP .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (05) :522-526
[5]  
Curtsinger JM, 1999, J IMMUNOL, V162, P3256
[6]  
Descamps V, 2001, ARCH DERMATOL, V137, P301
[7]   Natural adjuvants: Endogenous activators of dendritic cells [J].
Gallucci, S ;
Lolkema, M ;
Matzinger, P .
NATURE MEDICINE, 1999, 5 (11) :1249-1255
[8]   Danger signals: SOS to the immune system [J].
Gallucci, S ;
Matzinger, P .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (01) :114-119
[9]  
Gill HJ, 1997, J PHARMACOL EXP THER, V282, P795
[10]   The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole [J].
Gill, HJ ;
Maggs, JL ;
Madden, S ;
Pirmohamed, M ;
Park, K .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (03) :347-353